%0 Journal Article
%T Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
%A Lodewijk J.A. Toonen
%A Ronald A.M. Buijsen
%A Sarah L. Gardiner
%A Willeke M.C. van Roon-Mom
%J Archive of "Neurotherapeutics".
%D 2019
%R 10.1007/s13311-018-00696-y
%X Worldwide prevalence of polyglutamine spinocerebellar ataxias. In the ADCA families investigated, no SCA17 was identified. The Netherlands [8]; Germany [9]; Japan [10]; the USA [11]; Portugal/Brazil [12]; Italy [13]; China [14]; South Africa [15]; India [16]. Figure based on Schols et al. [17] and adapted from Bird [18] (GeneReviews
%K Spinocerebellar ataxia
%K SCA
%K polyglutamine disorders
%K gene therapy
%K stem cell-based therapy
%K antisense oligonucleotides
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554265/